Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Victory Genomics Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, WOOLWINE, SAMUEL C, who is the busiest examiner with 1 pending office action. This means the company's current patent prosecution is entirely dependent on the review of a single examiner within the patent office. For the practitioner, this suggests that the prosecution strategy should be highly tailored to the specific preferences and history of this one examiner.
The case is located within 1 distinct art unit. This concentration means the company's current patent prosecution is entirely dependent on the review of a single examiner within a single technical division of the patent office. This lack of distribution across different art units or examiners suggests a highly specialized invention that falls squarely within a single regulatory niche, requiring a focused and consistent legal approach during prosecution. Success in this matter will depend on a deep understanding of the assigned examiner's past rulings and technical standards.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOOLWINE, SAMUEL C | 1 | 61.0% | +20.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18635256 | METHODS FOR DETERMINING ANIMAL ANCESTERY AND FOR CONSERVATION THEREOF | WOOLWINE, SAMUEL C | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18635256 | METHODS FOR DETERMINING ANIMAL ANCESTERY AND FOR CONSERVATION THEREOF | WOOLWINE, SAMUEL C | 1681 | §112 | Non-Final OA | — | Pending | Apr 15, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVictory Genomics Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Samuel C Woolwine has the most, with 1 of Victory Genomics Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
